Wistar Institute Of Anatomy Biology

USPTO Trademark & Patent Filings

Wistar Institute Of Anatomy Biology

Trademark applications and grants for Wistar Institute Of Anatomy Biology. Wistar Institute Of Anatomy Biology has 4 trademark applications. The latest application filed is for "THE WISTAR INSTITUTE - DEVELOPING THE MEDICINE OF TOMORROW"

Company Profile
    Company Aliases
  • Wistar Institute of Anatomy and Biology
  • WISTAR INSTITUTE OF ANATOMY AND BIOLOGY, THE
  • The Wistar Institute Of Anatomy And Biology
  • biology anatomy of institute wistar
  • The Wistar Institute of Anatomy and Biology - Philadelphia PA US
  • THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY - Philadelphia PA US

Trademarks Patents
Patent Applications
Patent ApplicationDate
Methods for Monitoring Polymorphonuclear Myeloid Derived Suppressor Cells and Compositions and Methods of Treatment of Cancer
20210148916 - 16/943947 Gabrilovich; Dmitry I. ;   et al.
2021-05-20
Extreme Polyvalency Induces Potent Cross-Clade Cellular and Humoral Responses in Rabbits and Non-human Primates
20210138061 - 17/093927 Weiner; David ;   et al.
2021-05-13
METHODS AND COMPOSITIONS FOR TREATING CANCER
20210113613 - 16/635217 ERTL; HILDEGUND C.J. ;   et al.
2021-04-22
USE OF 6-THIO-2'-DEOXYGUANOSINE (6-THIO-dG) TO TREAT MELANOMA
20210113602 - 16/976456 SHAY; Jerry ;   et al.
2021-04-22
DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HIV
20210107970 - 16/497945 Weiner; David ;   et al.
2021-04-15
Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
10,987,353 - 16/098,753 Zhang , et al. April 27, 2
2021-04-27
Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
10,987,353 - 16/098,753 Zhang , et al. April 27, 2
2021-04-27
EBNA1 inhibitors and methods using same
10,981,867 - 16/571,896 Messick , et al. April 20, 2
2021-04-20
EBNA1 inhibitors and methods using same
10,981,867 - 16/571,896 Messick , et al. April 20, 2
2021-04-20
Compositions and methods of replication deficient adenoviral vectors for vaccine applications
10,953,108 - 16/322,139 Ertl , et al. March 23, 2
2021-03-23
Patent Grants & Applications

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed